Instituto do Cancer do Estado de São Paulo clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.

1. Notable

   ANTARES · Agnostic Therapy in Rare Solid Tumors

   Primary completion pushed from Jul 2026 to Jul 2027

   Also in this update: Enrollment closed, study ongoing; Trial sites reduced: 8 → 5 locations

   Instituto do Cancer do Estado de São Paulo·Phase 2· NCT06638931· Registry history of NCT06638931 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.